MedPath

Tianjin Medical University Cancer Institute & Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients

Conditions
Breast Cancer
Interventions
Procedure: Immediate Breast reconstruction
Procedure: Delayed Breast Reconstruction
Radiation: Radiation
First Posted Date
2018-11-16
Last Posted Date
2018-11-16
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
1344
Registration Number
NCT03743324

Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients

Not Applicable
Conditions
Breast Neoplasms
Interventions
Drug: Cefazolin/clindamycin
First Posted Date
2018-11-15
Last Posted Date
2018-11-15
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
291
Registration Number
NCT03742908
Locations
🇨🇳

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC

Phase 2
Completed
Conditions
Non Small Cell Lung Cancer
Interventions
First Posted Date
2018-11-09
Last Posted Date
2021-03-15
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
60
Registration Number
NCT03736837
Locations
🇨🇳

Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China

🇨🇳

Neimenggu Autonomous Region People's Hospital, Hohhot, Neimenggu, China

🇨🇳

Neimenggu Medical University Affiliated Hospital, Hohhot, Neimenggu, China

and more 2 locations

A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer

Phase 3
Conditions
Stage II Esophageal Cancer
Stage III Esophageal Cancer
Interventions
Combination Product: Neoadjuvant Radiochemotherapy
Combination Product: Definitive Radiochemotherapy
First Posted Date
2018-10-16
Last Posted Date
2018-10-16
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
220
Registration Number
NCT03708042

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Not Applicable
Conditions
Esophageal Cancer
Interventions
Radiation: IMRT or VMAT
First Posted Date
2018-09-14
Last Posted Date
2019-01-09
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
20
Registration Number
NCT03671265
Locations
🇨🇳

Department of Radiation Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China

Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing

Completed
Conditions
NSCLC
First Posted Date
2018-08-01
Last Posted Date
2018-08-07
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
513
Registration Number
NCT03609918

The Criteria for Lymph Node Sorting for Pathological Examination in Gastric Cancer

Not Applicable
Conditions
Gastric Cancer
Exanimation
Lymph Node Metastases
Interventions
Procedure: lymph node sorting for pathological examination
First Posted Date
2018-03-27
Last Posted Date
2020-11-13
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
276
Registration Number
NCT03478449
Locations
🇨🇳

Cancer Hospital of Tianjin Medical University, Tianjin, China

Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma

Not Applicable
Conditions
Hepatocellular Carcinoma
Interventions
Procedure: TACE
First Posted Date
2018-01-12
Last Posted Date
2018-01-12
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
248
Registration Number
NCT03398122
Locations
🇨🇳

Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Phase 3
Conditions
Vitamin D3
Interventions
Drug: Placebo
First Posted Date
2018-01-03
Last Posted Date
2018-01-03
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
750
Registration Number
NCT03389659

Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer

Not Applicable
Not yet recruiting
Conditions
Hypopharyngeal Carcinoma
Interventions
Radiation: Definitive radiotherapy
Procedure: Neck dissection followed by radiotherapy(50Gy) according to risk factors
First Posted Date
2017-12-11
Last Posted Date
2017-12-12
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
120
Registration Number
NCT03367884
Locations
🇨🇳

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath